Breast cancer

Open Access
From residual risk to precision intervention: the evolving role of minimal residual disease in breast cancer management
Junnan Xu, Kun Fang, Xiaoxi Li, Li Han, Shulan Sun and Tao Sun

Cancer Biology & Medicine November 2025, 20250431; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0431
Open Access
Comprehensive investigation of the molecular basis of cancer dependencies suggests therapeutic options for breast cancer
Rui Ding, Zhiming Shao and Tianjian Yu

Cancer Biology & Medicine October 2025, 20250290; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0290
Open Access
Lactate and lactylation in breast cancer: current understanding and therapeutic opportunities
Lan Huang, Xuemei Chen, Meina Yan, Ze Xiang and Jian Wu

Cancer Biology & Medicine July 2025, 22 (7) 789-805; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0173
Open Access
Nuclear PHGDH regulates macrophage polarization through transcriptional repression of GLUD1 and GLS2 in breast cancer
Pei Wang, Xin Du, Zhiren Han, Jiaxin Zhong, Jiayu Yuan, Lin Jiang, Beinan Han, Wenkui Fu, Hongde Li, Hai Hu and Zhenkun Na

Cancer Biology & Medicine May 2025, 22 (5) 502-524; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0398
Open Access
The treatment of breast cancer in the era of precision medicine
Jingwen Bai, Yiyang Gao and Guojun Zhang

Cancer Biology & Medicine April 2025, 22 (4) 322-347; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0510
Open Access
Clinical benefit and safety profile of cross-line therapy with CDK4/6 inhibitors: a retrospective study of HR+/HER2– advanced breast cancer
Qi Zhao, Mingxia Jiang, Jiaxuan Liu, Mengqi Zhang, Maiyue He, Shihan Zhou, Jiani Wang, Hongnan Mo, Bo Lan, Peng Yuan, Pin Zhang, Fei Ma, Qiao Li and Binghe Xu

Cancer Biology & Medicine October 2024, 21 (10) 934-950; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0204
Open Access
Research progress in tumor angiogenesis and drug resistance in breast cancer
Jiancheng Mou, Chenhong Li, Qinghui Zheng, Xuli Meng and Hongchao Tang

Cancer Biology & Medicine July 2024, 21 (7) 571-585; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0515
Open Access
ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis
Shirong Tan, Xiangyu Sun, Haoran Dong, Mozhi Wang, Litong Yao, Mengshen Wang, Ling Xu and Yingying Xu

Cancer Biology & Medicine July 2024, 21 (7) 606-635; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0309
Open Access
Decreased LDHB expression in breast tumor cells causes NK cell activation and promotes tumor progression
Zhihong Luo, Xiaohua Huang, Xinyi Xu, Kefeng Wei, Yi Zheng, Ke Gong and Wenhua Li

Cancer Biology & Medicine June 2024, 21 (6) 513-540; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0382
Open Access
Large-scale loss-of-function perturbations reveal a comprehensive epigenetic regulatory network in breast cancer
Yumei Wang, Haiyan Wang, Wei Shao, Yuhui Chen, Yu Gui, Chao Hu, Xiaohong Yi, Lijun Huang, Shasha Li and Dong Wang

Cancer Biology & Medicine January 2024, 21 (1) 83-103; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0276

Main menu

User menu

Search

Breast cancer

Pages

Navigate

More Information

For Authors

Journal Services